Summitt Labs Recalls CBD Tincture for Elevated Lead Levels

Summitt Labs announced last week it was voluntarily recalling Batch#730 Lot#K018 of its Kore Organic Watermelon CBD Oil Tincture.

Full story after the jump.

CBD manufacturer Summitt Labs announced it was recalling Batch#730 Lot#K018 of its Kore Organic Watermelon CBD Oil Tincture after the Florida Department of Agriculture and Consumer Services found lead levels of 4.7 ppm following a randomized test. The recall was first announced by the company on May 12 and was later published by the FDA on May 15.

FDA accompanied its announcement with the warning that the products’ lead levels were high enough to cause acute lead poisoning, symptoms of which include pain, muscle weakness, paresthesia, abdominal pain, nausea, vomiting, diarrhea, constipation, poor appetite, weight loss, encephalitis symptoms, a metallic taste in the mouth, shock, hemolysis, and kidney damage.

During its investigation, Summitt Labs tested another sample from the batch and found lead results of 500 ppb (.5ppm), which is within the legal limits; the company, however, still issued and plans to complete its voluntary recall.

“Any consumer with Lot #K018 Batch #730 in their possession are urged to contact Summitt Labs by phone at (833) 810-5673 Monday-Friday 8a.m. to 5p.m. EST, or through the website at www.Koreorganic.com. Any consumer with Lot #K018 Batch #730 should return this product to the place of purchase for a full monetary refund.” — FDA notice about Summitt Labs recall

The batch was distributed nationwide and can be identified by the Kore Organic Logo and Kraft Paper Packaging on the 30-milliliter bottle, pictured below.

Label photo provided via FDA.

The company was notifying distributors and customers alike of the recall via email, phone calls, and personal visits, FDA reported.

Get daily news insights in your inbox. Subscribe

End


Latest Cannabis News

View all news